NEW YORK (GenomeWeb News) – PerkinElmer and Corning will collaborate to develop label-free detection technologies for the drug discovery market, Corning said today.

Under the agreement, the companies will combine Corning's optical label-free detection technology with PerkinElmer's multi-label detection systems to offer next-generation drug discovery platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.